Primary Assessment Method
Title	10 mg kg−1 dose level
Number of patients enrolled	22
Number of patients evaluable for toxicity	22
Number of patients evaluated for efficacy	19
Evaluation method	RECIST 1.1
Response assessment, complete response	0 (0%)
Response assessment, partial response	0 (0%)
Response assessment, SD	10 (45.5%)
Response assessment, PD	9 (41%)
Response assessment, not evaluable	3 (15.5%)
Median duration assessments	2.1 months (95% CI: 1.4-5.5 months)